High-fat diet-induced
obesity is associated with a chronic state of low-grade
inflammation, which pre-disposes to
insulin resistance (IR), which can subsequently lead to
type 2 diabetes mellitus. Macrophages represent a heterogeneous population of cells that are instrumental in initiating the innate immune response. Recent studies have shown that macrophages are key mediators of
obesity-induced IR, with a progressive infiltration of macrophages into obese adipose tissue. These adipose tissue macrophages are referred to as classically activated (M1) macrophages. They release
cytokines such as IL-1β,
IL-6 and TNFα creating a pro-inflammatory environment that blocks adipocyte
insulin action, contributing to the development of IR and
type 2 diabetes mellitus. In lean individuals macrophages are in an alternatively activated (M2) state. M2 macrophages are involved in wound healing and immunoregulation. Wound-healing macrophages play a major role in tissue repair and homoeostasis, while immunoregulatory macrophages produce
IL-10, an anti-inflammatory
cytokine, which may protect against
inflammation. The functional role of T-cell accumulation has recently been characterised in adipose tissue. Cytotoxic T-cells are effector T-cells and have been implicated in macrophage differentiation, activation and migration. Infiltration of cytotoxic T-cells into obese adipose tissue is thought to precede macrophage accumulation. T-cell-derived
cytokines such as
interferon γ promote the recruitment and activation of M1 macrophages augmenting adipose tissue
inflammation and IR. Manipulating adipose tissue macrophages/T-cell activity and accumulation in vivo through
dietary fat modification may attenuate adipose tissue
inflammation, representing a therapeutic target for ameliorating
obesity-induced IR.